Biomolecules for Nuclear Imaging and Endoradiotherapy
A special issue of Biomolecules (ISSN 2218-273X). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 4017
Special Issue Editor
2. MedTechLabs, Stockholm, Sweden
Interests: radiochemistry; molecular imaging; endoradiotherapy; theranostics; cell tracking
Special Issue Information
Dear Colleagues,
Biomolecules is presenting a Special Issue on the use of biomolecules in nuclear medicine! Therefore, we are inviting you to submit your exciting, state-of-the-art research involving antibodies, peptides or other biomolecules for nuclear imaging and therapy.
The field of nuclear medicine focuses on the imaging and treatment of diseases using biologically active compounds that are labelled with radioactive isotopes. More often than not, these compounds are derived from biogenic substances that are involved in the disease process. For example, the standard radiotracer for positron emission tomography (PET) imaging is a radiolabelled analogue of sugar, highly taken up by fast-growing tumours. Similarly, novel treatment strategies are based on (fragments of) antibodies and peptides, targeting specific pathological pathways and which are labelled with therapeutic isotopes to irradiate the unhealthy cells.
We are welcoming review papers, original research manuscripts and high-quality communications that explore the use of biomolecules for nuclear imaging and endoradiotherapy.
Dr. Jeroen A.C.M. Goos
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Molecular Imaging
- Endoradiotherapy
- Radiotracers
- Radiopharmaceuticals
- Positron Emission Tomography
- Single-Photon Emission Computed Tomography
- Cerenkov Imaging
- Radioimmunotherapy
- Peptide Receptor Radionuclide Therapy
